Table 2.

Variables associated with locoregional control among all patients with PeCa (n = 51)

Variables	UVA		MVA
	HR (95% CI)	p value	HR (95% CI)	p value
ECOG	3.88 (1.38–10.92)	0.010	1.67 (0.49–5.76)	0.415
Tumor stage
T1	Reference	0.047	Reference	0.551
T2	1.42 (0.51–3.98)	0.500	1.44 (0.36–5.72)	0.605
T3	1.00 (0.31–3.19)	1.000	1.05 (0.28–3.98)	0.943
T4	54.27 (3.13–939.93)	0.006	9.25 (0.39–220.24)	0.169
Nodal stage
N0	Reference	0.014	Reference	0.027
N1	2.64 (0.43–16.01)	0.290	3.98 (0.57–27.64)	0.163
N2	7.67 (2.14–27.42)	0.002	7.99 (2.01–31.75)	0.003
N3	4.62 (0.92–23.17)	0.063	8.11 (1.30–50.48)	0.025
HPV/p16 status	0.42 (0.16–1.1)	0.076	0.41 (0.14–1.24)	0.116
Extent of surgery	2.27 (0.91–5.64)	0.079	2.10 (0.70–6.36)	0.187

Bold indicates statistical significance p values (< 0.05)

ECOG Eastern Cooperative Oncology Group performance status, UVA cox univariate analysis, MVA cox multivariate analysis, HR hazard ratio